Profile: Nilimedix deals with safer, easier to use and more economic tools for continuous subcutaneous insulin infusion for people with diabetes. Our patent-protected platform technology is based on a proprietary pressure triggered release mechanism, controlled by a system with valves and sensors. We provide ADI insulin that enables immediate detection of air within the insulin cartridge before it reaches the tubing, with an occlusion alarm to detect partial occlusion in the tubing due to sense changes in pressure between the body and the pumps. It also has an automatic screen indicating the number of insulin units in cartridges, overfilled cartridge detections, and magnesium housings.